Test Code YRIBO Riboflavin (Vitamin B2), Plasma
Additional Codes
YRIBO
VITAMIN B2
RIBOFLAVIN
Useful For
Assessment of riboflavin (vitamin B2) status
Assisting in the diagnosis of suspected vitamin B2 deficiency
Monitoring of vitamin B2 therapy
Method Name
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Portions of this test are covered by patents held by Quest Diagnostics
Reporting Name
Riboflavin (Vitamin B2), PSpecimen Type
Plasma HeparinShipping Instructions
Ship specimen in amber vial to protect from light.
Specimen Required
Patient Preparation:
Fasting: 12 hours, required; Infants should have specimen collected before next feeding
Supplies: Amber Frosted Tube, 5 mL (T915)
Collection Container/Tube:
Preferred: Green top (sodium or lithium heparin)
Acceptable: Light-green top (sodium or lithium heparin plasma gel)
Submission Container/Tube: Amber vial
Specimen Volume: 2 mL Plasma
Collection Instructions: Within 2 hours of collection, centrifuge and aliquot plasma into a amber vial.
Specimen Minimum Volume
Plasma: 0.5 mL
Specimen Stability Information
| Specimen Type | Temperature | Time | Special Container |
|---|---|---|---|
| Plasma Heparin | Refrigerated (preferred) | 28 days | LIGHT PROTECTED |
| Frozen | 28 days | LIGHT PROTECTED | |
| Ambient | 72 hours | LIGHT PROTECTED |
Reject Due To
| Gross hemolysis | OK |
| Gross lipemia | Reject |
| Gross icterus | OK |
Clinical Information
Riboflavin, which is commonly known as vitamin B2, is a water-soluble vitamin that is the precursor to the coenzymes flavin mononucleotide and flavin adenine dinucleotide. These coenzymes play a pivot role in a plethora of oxidation-reduction reactions, energy production, and metabolism of fats, drugs, and steroids.
Deficiency of riboflavin (ariboflavinosis) is characterized by sore throat, cheilosis (lesions on the lips), angular stomatitis (lesions on the angles of the mouth), glossitis (fissured and magenta-colored tongue), corneal vascularization, dyssebacia (red, scaly, greasy patches on the nose, eyelids, scrotum, and labia), and normocytic, normochromic anemia associated with pure red blood cell aplasia of the bone marrow. Riboflavin coenzymes play a key role in metabolism of vitamin B9 and vitamin B12, the activation of vitamin B6, and the conversion of tryptophan to vitamin B3. Therefore, deficiency of vitamin B2 can cause issues associated with other B vitamins as well. Early-stage symptoms of deficiency typically respond well to supplementation, but later stage anatomical changes cannot be reversed with therapy alone. Those at risk for vitamin B2 deficiency include those that are malnourished, vegan or vegetarian, individuals with hypothyroidism or adrenal insufficiency, pregnant and lactating women and their infants, and those on drugs with similar chemical structures such as tricyclic antidepressants.
In addition to dietary deficiency, there are rare inborn errors of metabolism, primarily involving loss of function of riboflavin transporters, which result in functional vitamin B2 deficiency. Many of these cases present with neurodegenerative features and/or hearing loss, which if left untreated can be fatal. In these cases, high-dose riboflavin supplementation is critical.
Riboflavin has a low level of toxicity and no case of riboflavin toxicity in humans has been reported. The limited absorptivity of riboflavin and its ready excretion in the urine normally precludes a health problem due to increased intake of riboflavin.
Reference Values
1-19 mcg/L
Interpretation
Low concentrations of vitamin B2 in the plasma are indicative of nutritional deficiency. Concentrations below 1 mcg/L are indicative of deficiency.
Cautions
Testing of nonfasting specimens or the use of dietary riboflavin (vitamin B2) supplementation can result in elevated plasma vitamin B2 concentrations. Reference intervals were established using specimens from individuals who were fasting.
Method Description
Riboflavin (vitamin B2) is extracted from plasma specimens with internal standard and then analyzed by liquid chromatography-tandem mass spectrometry.(Unpublished Mayo method)
Day(s) Performed
Monday, Wednesday, Friday
Report Available
2 to 5 daysPerforming Laboratory
Mayo Clinic Laboratories in Rochester
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
84252
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| VITB2 | Riboflavin (Vitamin B2), P | 2924-9 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| 61637 | Riboflavin (Vitamin B2), P | 2924-9 |